What to look forward to in GaBI Journal, 2012, issue 2
Equal protection under the law: Children and the Best Pharmaceuticals for Children Act
Tighter EU rules on pharmacovigilance for biologicals
What lessons can be learned from the launch of generic clopidogrel?
Generic clopidogrel–the medicines agency’s perspective
Generics substitution in primary care: summary of the Dutch community pharmacies guidelines
Oncologists urged to embrace biosimilars to help control spiralling costs of cancer care
Source URL: https://gabi-journal.net/20122-gabi-journal-table-of-contents.html
Copyright ©2024 GaBI Journal unless otherwise noted.